DiNapoli Sarah R, Hirsch Vanessa M, Brenchley Jason M
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
J Virol. 2016 Aug 12;90(17):7596-606. doi: 10.1128/JVI.00672-16. Print 2016 Sep 1.
The cells that are targeted by primate lentiviruses (HIV and simian immunodeficiency virus [SIV]) are of intense interest given the renewed effort to identify potential cures for HIV. These viruses have been reported to infect multiple cell lineages of hematopoietic origin, including all phenotypic and functional CD4 T cell subsets. The two most commonly reported cell types that become infected in vivo are memory CD4 T cells and tissue-resident macrophages. Though viral infection of CD4 T cells is routinely detected in both HIV-infected humans and SIV-infected Asian macaques, significant viral infection of macrophages is only routinely observed in animal models wherein CD4 T cells are almost entirely depleted. Here we review the roles of macrophages in lentiviral disease progression, the evidence that macrophages support viral replication in vivo, the animal models where macrophage-mediated replication of SIV is thought to occur, how the virus can interact with macrophages in vivo, pathologies thought to be attributed to viral replication within macrophages, how viral replication in macrophages might contribute to the asymptomatic phase of HIV/SIV infection, and whether macrophages represent a long-lived reservoir for the virus.
鉴于人们为寻找治疗艾滋病的潜在方法而重新做出努力,灵长类慢病毒(HIV和猴免疫缺陷病毒[SIV])所靶向的细胞备受关注。据报道,这些病毒可感染多种造血来源的细胞谱系,包括所有表型和功能的CD4 T细胞亚群。体内最常被报道受感染的两种细胞类型是记忆性CD4 T细胞和组织驻留巨噬细胞。虽然在感染HIV的人类和感染SIV的亚洲猕猴中都能常规检测到CD4 T细胞的病毒感染,但只有在CD4 T细胞几乎完全耗竭的动物模型中才能常规观察到巨噬细胞的显著病毒感染。在此,我们综述巨噬细胞在慢病毒疾病进展中的作用、巨噬细胞在体内支持病毒复制的证据、认为发生SIV巨噬细胞介导复制的动物模型、病毒在体内与巨噬细胞相互作用的方式、认为归因于巨噬细胞内病毒复制的病理情况、巨噬细胞中的病毒复制如何导致HIV/SIV感染的无症状期,以及巨噬细胞是否代表病毒的长期储存库。
Viruses. 2024-2-13
Semin Immunol. 2021-1
Trends Microbiol. 2016-3-21
J Clin Invest. 2016-4-1
Curr HIV/AIDS Rep. 2016-2
J Virol. 2015-11